Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 44,836 | 20,412 | 32,948 | 43,340 | 46,469 |
| Marketable Securities | 579 | 574 | 904 | 923 | 1,062 |
| Receivables | 1,802 | 2,122 | 1,437 | 1,032 | 1,025 |
| Other current assets | 0 | 0 | 2,953 | 0 | 0 |
| TOTAL | $49,368 | $24,623 | $39,143 | $47,591 | $49,995 |
| Non-Current Assets | |||||
| PPE Net | 9,087 | 8,015 | 5,590 | 7,637 | 4,396 |
| Intangibles | 108,025 | 109,001 | 80,405 | 111,154 | 117,949 |
| Other Non-Current Assets | 4,571 | 4,634 | 34,425 | 1,959 | 5,042 |
| TOTAL | $121,683 | $121,650 | $120,420 | $120,750 | $127,387 |
| Total Assets | $171,051 | $146,273 | $159,563 | $168,341 | $177,382 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,465 | 2,584 | 1,810 | 1,198 | 1,088 |
| Accrued Expenses | 10,276 | 9,576 | 8,652 | 9,893 | 16,450 |
| TOTAL | $14,154 | $13,955 | $14,120 | $13,377 | $19,775 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 178 | 541 |
| Other Non-Current Liabilities | 73,654 | 75,351 | 80,226 | 55,437 | 54,400 |
| TOTAL | $73,654 | $75,351 | $80,226 | $55,615 | $54,941 |
| Total Liabilities | $87,808 | $89,306 | $94,346 | $68,992 | $74,716 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,930 | 5,926 | 4,612 | 4,612 | 4,579 |
| Common Shares | 289,649 | 254,994 | 252,954 | 251,238 | 240,755 |
| Retained earnings | -206,437 | -198,065 | -187,774 | -151,889 | -138,089 |
| Other shareholders' equity | 31 | 38 | 37 | 0 | 0 |
| TOTAL | $83,243 | $56,967 | $65,217 | $99,349 | $102,666 |
| Total Liabilities And Equity | $171,051 | $146,273 | $159,563 | $168,341 | $177,382 |